NOVARTIS AG (NY:NVS)
53.13
0.16 (0.3%)
| NOVARTIS AG (NY:NVS) Delayed : |
| Previous Close |
$53.29 |
|
52 Week High |
$54.23 |
|
| Open |
$52.78 |
|
52 Week Low |
$33.34 |
| Day High |
$53.23 |
|
P/E |
N/A |
| Day Low |
$52.75 |
|
EPS |
$0.00 |
| Volume |
1,373,129 |
|
|
|
| More NVS Info:
Chart
SEC Filings
Profile
Historical
Options
|
Novartis AG Summary
Novartis AG provides healthcare solutions that address the needs of
patients and societies worldwide. Its Pharmaceuticals division
researches, develops, manufactures, distributes, and sells
pharmaceuticals in therapeutic areas, including cardiovascular and
metabolism; oncology and hematology; neuroscience; respiratory;
infectious diseases, transplantation, and immunology; ophthalmics,
dermatology, gastrointestinal, and urinary; and arthritis and ...more
Executives
Daniel Vasella - Chairman, CEO
Links
http://www.novartis.com/
-
Nov 16, 2009 11:10 AM
Notable Analyst Rating Changes 11/16: COH, JWN, GNK, ESEA, SVA, YGE Upgraded; PARD, GPS, JCP, DLTR Downgraded
-
Nov 16, 2009 07:08 AM
Deutsche Bank Initiates Coverage on Novartis (NVS) with a Buy
-
Nov 12, 2009 07:55 AM
Barclays Starts NVO, SNY at Overweight, GSK, AZN at Equalweight, NVS at Underweight
-
Nov 9, 2009 02:37 PM
Novartis (NVS) Acquires Majority Stake in Zhejiang Tianyuan Bio-Pharmaceutical for $125 Million
-
Oct 30, 2009 11:04 AM
Crucell NV (CRXL) Up On Renewed Takeover Chatter
View All Reports
StreetInsider Reports on NVS by Category
-
Nov 17, 2009 05:02 PM
Titan Pharmaceuticals: Finally Reaching Its Potential
-
Nov 16, 2009 11:55 AM
Analyst upgrades, downgrades and initiations: DLTR, JCP, JWN, LEA, RIMM, S ...
-
Nov 13, 2009 05:40 AM
Novartis Says Weak IP Protection Makes India R&D Impossible
-
Nov 9, 2009 10:19 AM
The Complete List of Swiss ADR Stocks
-
Nov 9, 2009 03:25 AM
D.C. Vaccine Conference: Why Investors Should Stay Tuned
View All Blogs
Comments on NVS
No comments are currently available.
on Nov 10, 2009
at 06:14 AM mbt shoes timberland pro boots Womens Roll-Top Boots Womens High Top Boots Womens 6 Inch Boots jack wills Apparel jackwills billy jack wills jack wills mbt trainers mbt shoes mbt shoe mbt sale
Article: Novartis (NVS) Acquires Majority Stake in Zhejiang Tianyuan Bio-Pharmaceutical for $125 Million
on Nov 10, 2009
at 06:09 AM ugg for sale Dunk SB Shoes air max 2009 nike air max 2009 Nike Air Max cardy ugg ugg classic boots UGG Boots UK UGG Boots Sale ugg for sale ugg shoes uggs shoes bailey button uggs
Article: Novartis (NVS) Acquires Majority Stake in Zhejiang Tianyuan Bio-Pharmaceutical for $125 Million
on Oct 15, 2009
at 12:26 PM HGSI BUY will get approved on lupus and go thru roof!
Article: Goldman Sachs Resumes Human Genome Sciences (HGSI) at Buy, Sees As Potential Takeover Target
on Oct 1, 2009
at 06:42 PM NVS NVS HAS THE BEST MANAGEMENT, HAS REC'D 1b FROM THE US GOV'T TO DEVELOP THE H1N1 VACCINE; ITS SALES AND CASH ARE REMARKABLE
Article: Jefferies & Co Upgrades Novartis (NVS) to Buy
on Oct 1, 2009
at 06:39 PM NVS WILL NVS PRODUCE THE BEST H1N1 VACCINE? iT'S MANAGEMENT IS THE BEST PLUS CASH AND SALES.
Article: Jefferies & Co Upgrades Novartis (NVS) to Buy